Study tests quick COVID-19 blood test for cancer patients
NCT ID NCT04492410
Summary
This study aimed to understand how common COVID-19 infections were among cancer patients during the pandemic. Researchers tested 214 cancer patients using a rapid finger-prick blood test that looks for COVID-19 antibodies. The goal was to gather data on infection rates, including in people without symptoms, to help hospitals better organize care and protect vulnerable patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
Conditions
Explore the condition pages connected to this study.